Sanford C. Bernstein set a €73.00 ($84.88) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report released on Tuesday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

A number of other analysts have also recently weighed in on FME. JPMorgan Chase & Co. set a €78.70 ($91.51) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Tuesday, November 5th. Independent Research set a €70.00 ($81.40) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Wednesday, October 30th. Deutsche Bank set a €100.00 ($116.28) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Wednesday, October 30th. Kepler Capital Markets set a €70.00 ($81.40) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Tuesday, October 29th. Finally, UBS Group set a €90.00 ($104.65) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Tuesday, October 29th. Eight research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus price target of €77.57 ($90.19).

Shares of FME stock traded down €0.34 ($0.40) during trading hours on Tuesday, reaching €65.48 ($76.14). The stock had a trading volume of 652,767 shares, compared to its average volume of 704,197. The company has a debt-to-equity ratio of 101.27, a current ratio of 0.98 and a quick ratio of 0.62. Fresenius Medical Care AG & Co. KGaA has a twelve month low of €55.44 ($64.47) and a twelve month high of €76.68 ($89.16). The firm has a 50-day simple moving average of €62.12 and a 200-day simple moving average of €65.49. The firm has a market capitalization of $19.97 billion and a PE ratio of 15.58.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

See Also: What are momentum indicators and what do they show?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.